期刊文献+

人羊膜间充质干细胞的生物学特性鉴定 被引量:7

Characterization of surface markers of human anmion mesenchym-derived side population cells
原文传递
导出
摘要 目的分离提纯的人羊膜间充质干细胞的生物学特性鉴定。方法剥去38~40周孕妇剖腹产术后羊膜,用消化酶消化后制备人羊膜间充质细胞(hAMCs)悬浮液。利用流式细胞分选技术从hAMCs中分离提纯干细胞(hAMC-SP细胞),并对于细胞抗原进行鉴定。结果从hAMCs中分离的hAMC-SP细胞,约占AMCs总数的0.3%。传代培养4~10代后的hAMC-SP细胞表达Nestin、Vimentin、整合素家属成员(CD49b、CD49c、CD49d、CD49e)、CD9、CD13、CD19、CD29、CD44、CD46、CD51、CD59、CD166及干细胞相关的Oct-3/4抗原。HLA-ABC、TRA-1-81及SSEA-4为弱表达;相反CD34、CD45、CD117、CD56、CD90、CD105、CD106、CD133、Fit-1、Musashi 1及HLA-DR无阳性结果,同样TRA-1-60及SSEA-3也表达阴性。体外转化实验表示hAMC-SP细胞在琼脂糖培养基上不形成细胞集落,但阳性对照组的HepG2形成多数细胞集落。结论hAMC-SP细胞表面标记符合骨髓及脂肪间充质等来源的干细胞特点;hAMC-SP细胞迅速而稳定扩增,无致瘤性。由于来源充足,hAMC-SP细胞在消除HLA-ABC阳性细胞亚群下,同种异体移植在内的广泛的再生医学领域中能成为理想的细胞来源。 Objective We aim to characterize the side population cells obtained by FACS from human amnion cells (hAMC) as stem cells. Methods hAMC were prepared by an enzymatic treatment from the amniotic membrane separated mechanically from the placenta obtained by Caesarean section of 38-40 weeks after pregnancy. SP cells(hAMC-SP) were isolated by FACS from them and studied for stem cell antigens. Results hAMC-SP cells were about 0.3% among hAMCs. The SP cells at fourth to tenth passages after the culture start were positive for Nestin, Vimentin, integrin family antigens (CD49b,CD49c .CD49d ,CD49e) and other antigens such as CD9, CD13, CD19, CD29, CD44, CD46, CD51, CD59, CD166, and Oct-3/4. HLA-ABC,TRA-1-81 and SSEA-4 were weakly positive. In contrast, CD34, CD45, CD117, CD56, CD90, CD105, CD106, CD133, Fit-1, Musashi and HLA-DR were negative. Similarly, TRA-1-60 and SSEA-3 were negative. The in vitro transformation assay revealed that hAMC-SP cells did not form colonies in soft agarose cultures, whereas HepG2 cells, used as the positive controls of transformed cells, formed many colonies. Conclusion The cell surface marker studies suggest that hAMC-SP share characteristics with the stem cells obtained from other organs such as bone marrow mesenchymal cells and fat tissues, hAMC-SP cells rapidly and stably proliferate without transforming and they indeed differentiate into several cell types upon exposure to differentiation media. These results suggest that hAMC- SP, after proper depletion of HLA-ABC positive populations, can be used as ideal stem cells in a wide range of regenerative medicine over allogenicity because of their abundant presence.
出处 《国际生物医学工程杂志》 CAS 北大核心 2010年第3期157-162,I0004,共7页 International Journal of Biomedical Engineering
基金 北京市教育委员会科技发展计划面上项目(KM200810025009) 留学人员科技活动择优资助(20080015)
关键词 羊膜间充质细胞 羊膜干细胞 表面标记 再生医学 Amnion mesenchymal cells Amnion stem ceils Surface marker Regeneration medicine
  • 相关文献

参考文献12

  • 1Papathanasopoulos A,Giannoudis PV.Biological considerations of mesenchymal stem cells and endothelial progenitor cells[J].Injury,2008,39 Suppl 2:S21-32.
  • 2LI Ning,PIAO Zheng-fu,Mamoru Kobayashi,Koji Sasaki,DING Shu-qin,Aiko Kikuchi,Isao Kamo,Norio Sakuragawa.Characterization of Side Cell Populations Obtained from Human Amnion Mesenchymal Cells[J].Chinese Journal of Biomedical Engineering(English Edition),2009,18(1):1-8. 被引量:1
  • 3Kobayashi M,Yakuwa T,Sasaki K,et al.Multilineage potential of side population cells from human amnion mesenchymal layer[J].Cell Transplant,2008,17(3):291-301.
  • 4Jiang Yue-hua,Jahagirdar BN,Reinhardt RL,et al.Pluripotency of mesenchymal stem cells derived from adult marrow[J].Nature,2002,418(6893):41-49.
  • 5Romanov YA,Darevskaya AN,Merzlikina NV,et al.Mesenchymal stem cells from human bone marrow and adipose tissue:isolation,characterization,and differentiation potentialities[J].Bull Exp Biol Med,2005,140(1):138-143.
  • 6Yanez R,Lamana ML,Garcia-Castro J,et al.Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease[J].Stem Cells,2006,24(11):2582-2591.
  • 7de Coppi P,Jr Bartsch G,Siddiqui MM,et al.Isolation of amniotic stem cell lines with potential for therapy[J].Nat Biotechnol,2007,25(1):100-106.
  • 8in't Anker PS,Noort WA,Kruisselbrink AB,et al.Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34+ cells in NOD/ SCID mice[J].Exp Hematol,2003,31(10):881-889.
  • 9Sakuragawa N,Misawa H,Ohsugi K,et al.Evidence for active acetylcholine metabolism in human amniotic epithelial cells:applicable to intracerebral allografting for neurologic disease[J].Neurosci Lett,1997,232(1):53-56.
  • 10Sundberg M,Jansson L,Ketolainen J,et al.CD marker expression profiles of human embryonic stem cells and their neural derivatives,determined using flow-cytometric analysis,reveal a novel CD marker for exclusion of pluripotent stem cells[J].Stem Cell Res,2009,2(2):113-124.

二级参考文献9

  • 1Sakuragawa N,,Yoshikawa J,Sasaki M.Amniotic tissue transplantation: clinical and biochemical evaluations for some lysosomal storage disease[].Brain and Development.1992
  • 2Parolini O,Alviano F,Bagnara GP, etal.Concise review:isolation and characterization of cells fromhuman term placenta: outcome of the firstinternational workshop on placenta derived stemcells[].StemCells.2008
  • 3Adinolfi M,Akle CA,McColl I, et al.Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells[].Nature.1982
  • 4Koyano S,Fukui A,Uchida S,Yamada K,Asashima M,Sakuragawa N.Synthesis and release of activin and noggin by cultured human amniotic epithelial cells[].Development Growth and Differentiation.2002
  • 5Sakuragawa,N.,Kakinuma,K.,Kikuchi,A.Human Amnion Mesenchyme Cells Express Phenotypes of Neuroglial Progenitor Cells[].Journal of Neuroscience Research.2004
  • 6Kobayashi M,Yakuwa T,Sasaki K,et al.Multilineage potential of side population cells from human amnion mesenchymal layer[].Cell Transplantation.2008
  • 7Sakuragawa N,Tohyama J,Yamamoto H.Immunostaining of human amniotic epithelial cells: possible use as a transgene carrier in gene therapy for inborn errors of metabolism[].Cell Transplantation.1995
  • 8Kues W A,Anger M,Carnwath J W,et al.Cell cycle synchronization of porcine fetal fibroblasts: effects of serum deprivation and reversible cell cycle inhibitors[].Biology of Reproduction.2000
  • 9Campagnoli C,Roberts I A,Kumar S,et al.Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow[].Blood.2001

同被引文献103

  • 1邓展生,张璇,邹冬青,许宇霞,胡懿合.骨碎补各种提取成分对人骨髓间充质干细胞的影响[J].中国现代医学杂志,2005,15(16):2426-2429. 被引量:36
  • 2李玮,漆洪波,孙江川.纤维蛋白支架上人羊膜上皮细胞的培养[J].中国病理生理杂志,2006,22(3):618-619. 被引量:5
  • 3翁慧男,王沂峰,刘风华.建立人阴道黏膜干细胞构建人工阴道的动物模型研究[J].中国实用妇科与产科杂志,2006,22(9):669-672. 被引量:12
  • 4ManuelpillaiU, Moodley Y, Bodongan C V, et al. Amniotic membrane and amniotic cells: Potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta,2011,32 (4) : 320-325.
  • 5ChangCJ, Yen M L, multipotent cells exhibit Chen Y C, et al. Placenta-derived e properties that are enhanced in the presence of interferon-gamma. Stem Cells,2006 24 : 2466 -2477.
  • 6Banas R A, Trumpower C, Jewski C B, et al. Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells. Human Immunology,2008,69:321-328.
  • 7Ilancheran S, Michalska A, Peb G, et al. Stem cells derived from human fetal membranes display muhilineage differentiation potential. Biol Reprod, 2007,77:577-588.
  • 8Bilic G, Zeisberger S M, Mallik A S, et al. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant, 2008,17:955-968.
  • 9Ilancheran S, Moodley Y, Manuelpillai U. Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta, 2009,50:2-10.
  • 10Tamagawa T, Oi S, Ishiwata I, et al. Differentiation of mesenchymal ceils derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum Cell, 2007,20:77-84.

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部